Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | ONCOLOGY//CELL BIOLOGY//BIOCHEMISTRY & MOLECULAR BIOLOGY | 2934640 |
200 | 3 | ONCOLOGY//PACLITAXEL//THYMIDYLATE SYNTHASE | 52806 |
1389 | 2 | PEMETREXED//NON SMALL CELL LUNG CANCER//ANTIFOLATE | 8368 |
826 | 1 | NON SMALL CELL LUNG CANCER//VINORELBINE//GEMCITABINE | 3066 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | NON SMALL CELL LUNG CANCER | authKW | 998380 | 33% | 10% | 1004 |
2 | VINORELBINE | authKW | 559686 | 7% | 24% | 228 |
3 | GEMCITABINE | authKW | 398305 | 13% | 10% | 398 |
4 | LUNG CANCER | journal | 359115 | 13% | 9% | 399 |
5 | PEMETREXED | authKW | 297725 | 5% | 19% | 154 |
6 | ADVANCED NON SMALL CELL LUNG CANCER | authKW | 291477 | 2% | 42% | 68 |
7 | DOCETAXEL | authKW | 254025 | 10% | 8% | 302 |
8 | CARBOPLATIN | authKW | 204899 | 8% | 9% | 230 |
9 | NSCLC | authKW | 170250 | 8% | 7% | 233 |
10 | ADVANCED NSCLC | authKW | 136521 | 1% | 39% | 34 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Oncology | 86187 | 85% | 0% | 2612 |
2 | Respiratory System | 21644 | 22% | 0% | 682 |
3 | Pharmacology & Pharmacy | 531 | 10% | 0% | 312 |
4 | Health Care Sciences & Services | 186 | 2% | 0% | 65 |
5 | Health Policy & Services | 73 | 1% | 0% | 33 |
6 | Critical Care Medicine | 72 | 1% | 0% | 40 |
7 | Medicine, General & Internal | 72 | 4% | 0% | 124 |
8 | Geriatrics & Gerontology | 22 | 1% | 0% | 23 |
9 | Hematology | 4 | 1% | 0% | 37 |
10 | Integrative & Complementary Medicine | 1 | 0% | 0% | 7 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | PULM DIS 1 | 68511 | 0% | 67% | 10 |
2 | MED ONCOL | 50751 | 16% | 1% | 497 |
3 | MULTIDISCIPLINARY THORAC ONCOL PROGRAM | 43547 | 1% | 20% | 21 |
4 | LUNG CANC WORKING GRP | 41110 | 0% | 100% | 4 |
5 | THORAC ONCOL | 40344 | 3% | 4% | 94 |
6 | ONCOL EMERGING MARKETS | 32887 | 0% | 80% | 4 |
7 | DIS MANAGEMENT TEAM LUNG CANC | 32114 | 0% | 63% | 5 |
8 | CHEST DIS 1 | 30833 | 0% | 100% | 3 |
9 | CHEST DIS 2 | 30833 | 0% | 100% | 3 |
10 | CHEST DIS 7 | 30833 | 0% | 100% | 3 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | LUNG CANCER | 359115 | 13% | 9% | 399 |
2 | SEMINARS IN ONCOLOGY | 136395 | 9% | 5% | 263 |
3 | CLINICAL LUNG CANCER | 52672 | 2% | 8% | 66 |
4 | JOURNAL OF THORACIC ONCOLOGY | 45601 | 4% | 4% | 111 |
5 | ANNALS OF ONCOLOGY | 30544 | 5% | 2% | 159 |
6 | CANCER TREATMENT REPORTS | 28272 | 3% | 4% | 78 |
7 | AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | 21638 | 3% | 2% | 93 |
8 | JOURNAL OF CLINICAL ONCOLOGY | 20746 | 6% | 1% | 183 |
9 | CANCER CHEMOTHERAPY AND PHARMACOLOGY | 17372 | 4% | 2% | 113 |
10 | PROGRESS IN RESPIRATORY RESEARCH | 6571 | 0% | 16% | 4 |
Author Key Words |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | NON SMALL CELL LUNG CANCER | 998380 | 33% | 10% | 1004 | Search NON+SMALL+CELL+LUNG+CANCER | Search NON+SMALL+CELL+LUNG+CANCER |
2 | VINORELBINE | 559686 | 7% | 24% | 228 | Search VINORELBINE | Search VINORELBINE |
3 | GEMCITABINE | 398305 | 13% | 10% | 398 | Search GEMCITABINE | Search GEMCITABINE |
4 | PEMETREXED | 297725 | 5% | 19% | 154 | Search PEMETREXED | Search PEMETREXED |
5 | ADVANCED NON SMALL CELL LUNG CANCER | 291477 | 2% | 42% | 68 | Search ADVANCED+NON+SMALL+CELL+LUNG+CANCER | Search ADVANCED+NON+SMALL+CELL+LUNG+CANCER |
6 | DOCETAXEL | 254025 | 10% | 8% | 302 | Search DOCETAXEL | Search DOCETAXEL |
7 | CARBOPLATIN | 204899 | 8% | 9% | 230 | Search CARBOPLATIN | Search CARBOPLATIN |
8 | NSCLC | 170250 | 8% | 7% | 233 | Search NSCLC | Search NSCLC |
9 | ADVANCED NSCLC | 136521 | 1% | 39% | 34 | Search ADVANCED+NSCLC | Search ADVANCED+NSCLC |
10 | CHEMOTHERAPY | 107478 | 19% | 2% | 578 | Search CHEMOTHERAPY | Search CHEMOTHERAPY |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |